First-Trimester Pregnancy Exposure to Venlafaxine or Duloxetine and Risk of Major Congenital Malformations: A Systematic Review (Q38599005)

4 September 2017

title

First-Trimester Pregnancy Exposure to Venlafaxine or Duloxetine and Risk of Major Congenital Malformations: A Systematic Review (English)

1 reference

4 September 2017

0 references

0 references

Per Damkier

0 references

Dorte Lassen

1 reference

4 September 2017

publication date

5 October 2015

1 reference

Basic and Clinical Pharmacology and Toxicology

4 September 2017

published in

1 reference

4 September 2017

volume

118

1 reference

4 September 2017

1 reference

4 September 2017

page(s)

32-36

1 reference

Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian Mother and Child Cohort Study

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12497

Impact of maternal depression on pregnancies and on early attachment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12497

Complex challenges in treating depression during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12497

Antidepressant exposure during pregnancy and congenital malformations: is there an association? A systematic review and meta-analysis of the best evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12497

Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12497

Selective Serotonin Reuptake Inhibitors (SSRIs) and the Risk of Congenital Heart Defects: A Meta-Analysis of Prospective Cohort Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12497

Antidepressant use in pregnancy and the risk of cardiac defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12497

Antidepressant exposure during the first trimester does not increase the risk of cardiac malformations in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12497

Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12497

The safety of duloxetine during pregnancy and lactation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12497

Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12497

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders. part 2: maintenance treatment of major depressive disorder-update 2015.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12497

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12497

Incidence of major malformations in infants following antidepressant exposure in pregnancy: results of a large prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12497

Newer antidepressants in pregnancy: prospective outcome of a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12497

Duloxetine transfer across the placenta during pregnancy and into milk during lactation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12497

Duloxetine withdrawal syndrome in a newborn.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12497

Infant health and neurodevelopmental outcomes following prenatal exposure to duloxetine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12497

Poor neonatal adaptation after in utero exposure to duloxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12497

Use of duloxetine in pregnancy and lactation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12497

Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12497

Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12497

Rates of major malformations in infants following exposure to duloxetine during pregnancy: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12497

Duloxetine and pregnancy outcomes: safety surveillance findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12497

Safety and tolerability of duloxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo-controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12497

The use of central nervous system active drugs during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12497

The Nordic countries as a cohort for pharmacoepidemiological research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12497

The safety of serotonin-noradrenaline reuptake inhibitors (SNRIs) in pregnancy and breastfeeding: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12497

Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12497

21 January 2018

Identifiers

DOI

10.1111/BCPT.12497

1 reference

4 September 2017

1 reference